Increased apoptosis in gastric mucosa adjacent to intestinal metaplasia
Open Access
- 1 May 2003
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 56 (5) , 358-361
- https://doi.org/10.1136/jcp.56.5.358
Abstract
Background: The biological processes involved in the development of gastric mucosal atrophy and intestinal metaplasia are still incompletely understood. Reports testing the hypothesis that apoptosis leads to atrophy have yielded conflicting results. The availability of new antibodies for the detection of apoptotic cells in tissue sections has facilitated the analysis of the role of apoptosis in the gastritis–atrophy–intestinal metaplasia sequence. Methods: Archival material from 40 gastric resection specimens with normal mucosa (n = 5), chronic active gastritis (n = 17), or intestinal metaplasia (n = 18) was studied. Immunohistochemistry was performed using antibodies directed against cleaved cytokeratin 18 and active caspase 3. Slides were scored on a 0–3 scale for the presence of apoptotic cells. Results: Normal gastric mucosa contained low numbers of apoptotic cells at the surface epithelium (mean score, 0.20). This number was significantly increased in cases with chronic gastritis (mean score, 1.06) and in those with intestinal metaplasia (mean score, 2.56). Within the intestinal metaplasia cases, 44 different foci of intestinal metaplasia were identified. In 39 of these 44 areas, concentrations of apoptotic cells were seen immediately adjacent to the foci of intestinal metaplasia, but not in the metaplastic epithelium itself. Conclusions: Apoptosis is uncommon in normal gastric mucosa. Chronic inflammation and intestinal metaplasia are associated with increased apoptosis, but occur mainly at the mucosal surface and not in the deeper layers. These findings do not support the concept that apoptosis underlies the loss of gastric glands and leads to atrophy, but the observed concentration of apoptotic epithelial cells adjacent to foci of intestinal metaplasia could be related to heterogeneity of epithelial damage, causing apoptosis, to which intestinal metaplasia is a response.Keywords
This publication has 29 references indexed in Scilit:
- Atrophy–metaplasia–dysplasia–carcinoma sequence in the stomach: a reality or merely an hypothesis?Best Practice & Research Clinical Gastroenterology, 2001
- Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infectionJournal of Clinical Pathology, 2000
- Decreased expression of fas (CD95/AP01)associated with goblet cell metaplasia in barrett's esophagusHuman Pathology, 2000
- Trefoil peptidesGut, 1999
- Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.Journal of Clinical Investigation, 1998
- Caspases: Enemies WithinScience, 1998
- Induction of gastric epithelial apoptosis by Helicobacter pylori.Gut, 1996
- Long-term sequelae of Helicobacter pylori gastritisThe Lancet, 1995
- In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary noteHepatology, 1995
- Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.Gut, 1991